← Eichor
Condition: Intranasal Administration Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Intranasal Administration

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillations for St
Phase 1 · 2 location(s) · The Foundation for Orthopaedics and Regenerative Medicine · NCT05158101Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease
Phase 1 · 1 location(s) · The Foundation for Orthopaedics and Regenerative Medicine · NCT05152394Effect of Intranasal Breast Milk Administration in Preterm Infants
NA · 1 location(s) · Selcuk University · NCT06706115Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
Phase 3 · 1 location(s) · Assaf-Harofeh Medical Center · NCT06067958Topical TOR-582 Treatment of Epistaxis in HHT
Phase 1 · 1 location(s) · Columbia University · NCT07667413Randomized Clinical Trial of Intranasal Injection of Platelet-Rich Plasma for Treatment of Parosmia
NA · 1 location(s) · Stanford University · NCT06283745RIG 101 Trial in Healthy Adults and Adults With Asthma
Phase 1/Phase 2 · 2 location(s) · RIGImmune Inc. · NCT07488897Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
Phase 4 · 7 location(s) · Daniel Merenstein · NCT06076304Intranasal Insulin for Treatment of Alcohol Use Disorder
Phase 1/Phase 2 · 1 location(s) · Brown University · NCT05988632Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06051227Esketamine With or Without Integration Therapy for Treatment-Resistant Depression
Phase 4 · 2 location(s) · University of Puerto Rico · NCT07369102Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS
Phase 1/Phase 2 · 1 location(s) · Xuanwu Hospital, Beijing · NCT06598202Administration of Intranasal Midazolam for Anxiety in Palliative Care
Phase 2 · 5 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06330584The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi
NA · 1 location(s) · Sun Fei · NCT07324057Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
Phase 1 · 1 location(s) · Johns Hopkins University · NCT06805994Nebulized Fentanyl in Healthy Volunteers
Phase 1 · 1 location(s) · University Hospital, Rouen · NCT06281951Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients
Phase 4 · 1 location(s) · Peking University First Hospital · NCT07479602Intranasal Dexmedetomidine for Acute Anxiety State in Adults
Phase 2 · 1 location(s) · Tongji University · NCT07550881Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage
Phase 4 · 1 location(s) · Wright State University · NCT07116408Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT
Phase 2 · 1 location(s) · St. Olavs Hospital · NCT06757517Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Witho
Phase 3 · 21 location(s) · Optinose US Inc. · NCT06850805
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.